Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C1 | Q04828 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7666255 | 1.00 | AKR1C1 (0.58) | AKR1C1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL9239140 | 0.88 | ALDH1A1 (0.51) | AKR1C1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL8805362 | 0.86 | KMT2A (0.58) | AKR1C1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL8805358 | 0.86 | KMT2A (0.58) | AKR1C1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL8648115 | 0.85 | ALDH1A1 (0.60) | AKR1C1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL8648112 | 0.85 | ALDH1A1 (0.60) | AKR1C1KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL7666908 | 0.82 | LMNA (0.54) | KMT2AMEN1ALDH1A1LMNAHPGD | |
| SCHEMBL7666912 | 0.82 | LMNA (0.54) | KMT2AMEN1ALDH1A1LMNAHPGD | |
| SCHEMBL8644175 | 0.79 | KMT2A (0.43) | KMT2AMEN1ALDH1A1LMNAHPGD | |
| SCHEMBL8644173 | 0.79 | KMT2A (0.43) | KMT2AMEN1ALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6624197-B1 | Styrene administered orally to decrease blood glucose levels in rats. The glucose tolerance in insulin resistant rats is also shown, as well as lowering of triglyceride levels in serum insulin resistant, hyperinsulinemic and | CALYX THERAPEUTICS, INC. | 2003-09-23 | — | — | US | disclosed |
| US-6492531-B1 | THE INVENTION CONCERNS CHOLECYSTOKININ (CCK) ANTAGONISTS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS. ESPECIALLY USEFUL ARE CCK.SUB.B ANTAGONISTS SUCH AS CI-988. | WARNER-LAMBERT COMPANY | 2002-12-10 | — | — | US | disclosed |
| EP-0729752-A2 | Central cholecystokinin antagonists having pharmaceutical activity | MERCK SHARP & DOHME LTD. (GB) | 1996-09-04 | — | — | EP | disclosed |
| WO-1993012817-A1 | THERAPEUTIC COMBINATIONS USEFUL IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE | WARNER-LAMBERT COMPANY (US) | 1993-07-08 | — | — | WO | disclosed |